A citation-based method for searching scientific literature

Bimal P Chaudhari, Kandamurugu Manickam, Kim L McBride. Pediatr Res 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A review of consent practices and perspectives for pharmacogenetic testing.
Susanne B Haga, Rachel Mills. Pharmacogenomics 2016
8
100

The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists.
Kym Boycott, Taila Hartley, Shelin Adam, Francois Bernier, Karen Chong, Bridget A Fernandez, Jan M Friedman, Michael T Geraghty, Stacey Hume, Bartha M Knoppers,[...]. J Med Genet 2015
119
100

Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics.
Carla G van El, Martina C Cornel, Pascal Borry, Ros J Hastings, Florence Fellmann, Shirley V Hodgson, Heidi C Howard, Anne Cambon-Thomsen, Bartha M Knoppers, Hanne Meijers-Heijboer,[...]. Eur J Hum Genet 2013
206
100

A Tutorial for Pharmacogenomics Implementation Through End-to-End Clinical Decision Support Based on Ten Years of Experience from PREDICT.
Michelle Liu, Cindy L Vnencak-Jones, Bartholomew P Roland, Cheryl L Gatto, Janos L Mathe, Shari L Just, Josh F Peterson, Sara L Van Driest, Asli O Weitkamp. Clin Pharmacol Ther 2021
11
100

Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
Laura M Amendola, Michael O Dorschner, Peggy D Robertson, Joseph S Salama, Ragan Hart, Brian H Shirts, Mitzi L Murray, Mari J Tokita, Carlos J Gallego, Daniel Seung Kim,[...]. Genome Res 2015
225
100

Evaluation of population-level pharmacogenetic actionability in Alabama.
Brittney H Davis, Kelly Williams, Devin Absher, Bruce Korf, Nita A Limdi. Clin Transl Sci 2021
3
100

Whole-genome sequencing for optimized patient management.
Matthew N Bainbridge, Wojciech Wiszniewski, David R Murdock, Jennifer Friedman, Claudia Gonzaga-Jauregui, Irene Newsham, Jeffrey G Reid, John K Fink, Margaret B Morgan, Marie-Claude Gingras,[...]. Sci Transl Med 2011
180
100

Incidental SOS1 variant identified by non-invasive prenatal screening: Prenatal diagnosis and family clinical reassessment.
Gioia Mastromoro, Daniele Guadagnolo, Enrica Marchionni, Francesca Di Palma, Laura Gigante, Paolo Versacci, Flavia Ventriglia, Marina Baldi, Antonio Pizzuti. Eur J Obstet Gynecol Reprod Biol 2021
1
100

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
226
100

A 14-year-old in heart failure with multiple cardiomyopathy variants illustrates a role for signal-to-noise analysis in gene test re-interpretation.
Patrick S Connell, Aamir Jeewa, Debra L Kearney, Hari Tunuguntla, Susan W Denfield, Hugh D Allen, Andrew P Landstrom. Clin Case Rep 2018
5
100


Individualized Medication Management in Ontario Long-Term Care Clinical Impact on Management of Depression, Pain, and Dementia.
Ruslan Dorfman, Zana London, Mark Metias, Boyko Kabakchiev, Gouri Mukerjee, Andrea Moser. J Am Med Dir Assoc 2020
9
100

Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial.
Yvonne Bombard, Marc Clausen, Salma Shickh, Chloe Mighton, Selina Casalino, Theresa H M Kim, Sarah M Muir, Lindsay Carlsson, Nancy Baxter, Adena Scheer,[...]. Genet Med 2020
10
100


Towards realizing the vision of precision medicine: AI based prediction of clinical drug response.
Johann de Jong, Ioana Cutcutache, Matthew Page, Sami Elmoufti, Cynthia Dilley, Holger Fröhlich, Martin Armstrong. Brain 2021
4
100

Reanalysis of Clinical Exome Sequencing Data.
Pengfei Liu, Linyan Meng, Elizabeth A Normand, Fan Xia, Xiaofei Song, Andrew Ghazi, Jill Rosenfeld, Pilar L Magoulas, Alicia Braxton, Patricia Ward,[...]. N Engl J Med 2019
72
100


Evidence for extensive pleiotropy among pharmacogenes.
Matthew T Oetjens, William S Bush, Joshua C Denny, Kelly Birdwell, Nuri Kodaman, Anurag Verma, Holli H Dilks, Sarah A Pendergrass, Marylyn D Ritchie, Dana C Crawford. Pharmacogenomics 2016
8
100

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Stacy W Gray, Elyse R Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth Bair, Joshua Gagne, Judy Garber, Pasi A Jänne, Neal Lindeman,[...]. Genet Med 2016
71
100


Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests.
Christel Thauvin-Robinet, Julien Thevenon, Sophie Nambot, Julian Delanne, Paul Kuentz, Ange-Line Bruel, Aline Chassagne, Elodie Cretin, Aurore Pelissier, Chritine Peyron,[...]. Eur J Hum Genet 2019
7
100

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.
Matthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, Matthias Schwab, Michael Province, Michelle Whirl-Carrillo, W Fraser Symmans, Howard L McLeod, Mark J Ratain, Hitoshi Zembutsu,[...]. Clin Pharmacol Ther 2018
133
100

Collaborative Counseling Considerations for Pharmacogenomic Tests.
Heather A Zierhut, Colleen A Campbell, Allison G Mitchell, Amy A Lemke, Rachel Mills, Jeffrey R Bishop. Pharmacotherapy 2017
18
100

Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
Ina Liko, Lisa Corbin, Eric Tobin, Christina L Aquilante, Yee Ming Lee. Am J Health Syst Pharm 2021
2
100

Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
Gerard Clarke, Kiran V Sandhu, Brendan T Griffin, Timothy G Dinan, John F Cryan, Niall P Hyland. Pharmacol Rev 2019
93
100

ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
David T Miller, Kristy Lee, Wendy K Chung, Adam S Gordon, Gail E Herman, Teri E Klein, Douglas R Stewart, Laura M Amendola, Kathy Adelman, Sherri J Bale,[...]. Genet Med 2021
28
100

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
Kristine R Crews, Andrew A Monte, Rachel Huddart, Kelly E Caudle, Evan D Kharasch, Andrea Gaedigk, Henry M Dunnenberger, J Steven Leeder, John T Callaghan, Caroline Flora Samer,[...]. Clin Pharmacol Ther 2021
34
100

A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record.
J K Hicks, K R Crews, J M Hoffman, N M Kornegay, M R Wilkinson, R Lorier, A Stoddard, W Yang, C Smith, C A Fernandez,[...]. Clin Pharmacol Ther 2012
72
100


Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
Martin Fassnacht, Wiebke Arlt, Irina Bancos, Henning Dralle, John Newell-Price, Anju Sahdev, Antoine Tabarin, Massimo Terzolo, Stylianos Tsagarakis, Olaf M Dekkers. Eur J Endocrinol 2016
560
100

Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience.
Elizabeth M J Lee, Karen Xu, Emma Mosbrook, Amanda Links, Jessica Guzman, David R Adams, Elise Flynn, Elise Valkanas, Camillo Toro, Cynthia J Tifft,[...]. Genet Med 2016
10
100

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
100

Incidental findings on brain MRI in the general population.
Meike W Vernooij, M Arfan Ikram, Hervé L Tanghe, Arnaud J P E Vincent, Albert Hofman, Gabriel P Krestin, Wiro J Niessen, Monique M B Breteler, Aad van der Lugt. N Engl J Med 2007
877
100

Precision medicine meets public health: population screening for BRCA1 and BRCA2.
Ephrat Levy-Lahad, Amnon Lahad, Mary-Claire King. J Natl Cancer Inst 2014
38
100

Detection of incidental cardiac findings in noncardiac chest computed tomography.
Francesco Secchi, Giovanni Di Leo, Moreno Zanardo, Marco Alì, Paola Maria Cannaò, Francesco Sardanelli. Medicine (Baltimore) 2017
8
100

Patient Decisions to Receive Secondary Pharmacogenomic Findings and Development of a Multidisciplinary Practice Model to Integrate Results Into Patient Care.
J Kevin Hicks, Amy Shealy, Allison Schreiber, Marissa Coleridge, Ryan Noss, Marvin Natowicz, Rocio Moran, Timothy Moss, Angelika Erwin, Charis Eng. Clin Transl Sci 2018
7
100

Laboratory and Clinical Implications of Incidental and Secondary Germline Findings During Tumor Testing.
Allison Cushman-Vokoun, Josh Lauring, John Pfeifer, Damon R Olson, Anna Berry, John Thorson, Karl Voelkerding, Jonathan Myles, James Barbeau, Pranil Chandra,[...]. Arch Pathol Lab Med 2022
2
100

Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.
Jacob T Brown, Jeffrey R Bishop, Katrin Sangkuhl, Erika L Nurmi, Daniel J Mueller, Jean C Dinh, Andrea Gaedigk, Teri E Klein, Kelly E Caudle, James T McCracken,[...]. Clin Pharmacol Ther 2019
57
100

Ancillary risk information and pharmacogenetic tests: social and policy implications.
N B Henrikson, W Burke, D L Veenstra. Pharmacogenomics J 2008
29
100

Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing.
Adam A Nishimura, Brian H Shirts, Michael O Dorschner, Laura M Amendola, Joe W Smith, Gail P Jarvik, Peter Tarczy-Hornoch. Genet Med 2015
16
100

Gut microbiota modulates drug pharmacokinetics.
Juanhong Zhang, Junmin Zhang, Rong Wang. Drug Metab Rev 2018
35
100


Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
Wan-Chun Chang, Reo Tanoshima, Colin J D Ross, Bruce C Carleton. Annu Rev Pharmacol Toxicol 2021
4
100

Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.
Diana W Bianchi, Darya Chudova, Amy J Sehnert, Sucheta Bhatt, Kathryn Murray, Tracy L Prosen, Judy E Garber, Louise Wilkins-Haug, Neeta L Vora, Stephen Warsof,[...]. JAMA 2015
207
100

Guidelines for diagnostic next-generation sequencing.
Gert Matthijs, Erika Souche, Mariëlle Alders, Anniek Corveleyn, Sebastian Eck, Ilse Feenstra, Valérie Race, Erik Sistermans, Marc Sturm, Marjan Weiss,[...]. Eur J Hum Genet 2016
48
100


Implementation of a pharmacogenomics service in a community pharmacy.
Stefanie P Ferreri, Angelo J Greco, Natasha M Michaels, Shanna K O'Connor, Rebecca W Chater, Anthony J Viera, Hawazin Faruki, Howard L McLeod, Mary W Roederer. J Am Pharm Assoc (2003) 2014
54
100

Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.
Susanne B Haga, Julianne M O'Daniel, Genevieve M Tindall, Isaac R Lipkus, Robert Agans. Genet Med 2011
41
100

Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.
J Kevin Hicks, Nihal El Rouby, Henry H Ong, Jonathan S Schildcrout, Laura B Ramsey, Yaping Shi, Leigh Anne Tang, Christina L Aquilante, Amber L Beitelshees, Kathryn V Blake,[...]. Clin Pharmacol Ther 2021
6
100

The challenges of implementing pharmacogenomic testing in the clinic.
Ann M Moyer, Pedro J Caraballo. Expert Rev Pharmacoecon Outcomes Res 2017
24
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.